ImmuCell Corp. (ICCC)
5.94
+0.37
(+6.64%)
USD |
NASDAQ |
Dec 10, 16:00
5.94
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Profit Margin (Quarterly): -2.54% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 24.85% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
| Theriva Biologics, Inc. | -- |
| Oragenics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.15% |
| Return on Assets | 5.11% |
| Return on Invested Capital | 5.39% |
| Gross Profit Margin (Quarterly) | 42.92% |
| Operating Margin (Quarterly) | 0.37% |
| Return on Net Operating Assets | 5.66% |